Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-26 @ 10:34 AM
NCT ID:
NCT02212028
Eligibility Criteria:
Inclusion criteria:
* Patients with ST-elevation myocardial infarction undergoing primary PCI
* Age between 18 and 75 years old
Exclusion criteria:
* Age \>75 years
* Weight \<60 Kg
* On treatment with a P2Y12 receptor antagonist (ticlopidine, clopidogrel, prasugrel, ticagrelor) in past 7 days
* Known allergies to aspirin or prasugrel
* Considered at high risk for bleeding
* History of ischemic or hemorrhagic stroke or transient ischemic attack
* On treatment with oral anticoagulant (Vitamin K antagonists, dabigatran, rivaroxaban, apixaban)
* Treatment with IIb/IIIa glycoprotein inhibitors
* Fibrinolytics within 24 hours
* Known blood dyscrasia or bleeding diathesis
* Known platelet count \<80x106/mL
* Known hemoglobin \<10 g/dL
* Active bleeding
* Hemodynamic instability
* Known creatinine clearance \<30 mL/minute
* Known severe hepatic dysfunction
* Pregnant females\*
* Women of childbearing age must use reliable birth control (i.e. oral contraceptives) while participating in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02212028
Study Brief:
Protocol Section:
NCT02212028